in mice used in type 1 diabetes T1D research, the team reported in the article "A Gut Microbial Peptide and Molecular Mimicry in the Pathogenesis of Type 1 Diabetes." This bacterium is most likely ...

Type 1 diabetes occurs when the immune system attacks pancreatic beta cells. Type 2 diabetes happens when the body cannot use insulin effectively. The two types differ in symptoms, causes ...

Type 1 diabetes represents an autoimmune condition ... oral medications that address various aspects of the condition’s pathophysiology may be added. These include: Medications that improve ...

Antibiotics in infancy may impair insulin cell growth, increasing diabetes risk, while certain microbes could help promote ...

Modern genetic research identifies multiple genes involved in both diabetes types. Type 1 diabetes shows strong associations with specific immune system genes, while type 2 demonstrates broader ...

aDepartment of Paediatrics and Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL, USA ...

A new study sheds light on changes to the fetus's bile acid, which affects ... New Tech for Managing Type 1 Diabetes Is Effective for Older Adults Mar. 11, 2025 — New research suggests that ...

Diabetic neuropathy is a serious and common complication of type 1 and type 2 diabetes. The condition usually develops slowly, sometimes over the course of several decades. If you have diabetes ...

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the pancreas and may boost ...

Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice ...

The differences in type 1 diabetes pathogenesis between rodents and humans, as well as other immunotherapeutic approaches, have been extensively reviewed elsewhere (e.g., [1–3]). Here ...